DK2123271T3 - Lægemiddel til behandling af influenza - Google Patents
Lægemiddel til behandling af influenzaInfo
- Publication number
- DK2123271T3 DK2123271T3 DK08721158.7T DK08721158T DK2123271T3 DK 2123271 T3 DK2123271 T3 DK 2123271T3 DK 08721158 T DK08721158 T DK 08721158T DK 2123271 T3 DK2123271 T3 DK 2123271T3
- Authority
- DK
- Denmark
- Prior art keywords
- influenza
- medication
- treatment
- prophylactic
- therapeutic
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 206010064097 avian influenza Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007056872 | 2007-03-07 | ||
| PCT/JP2008/053738 WO2008108323A1 (ja) | 2007-03-07 | 2008-03-03 | インフルエンザ治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2123271T3 true DK2123271T3 (da) | 2012-01-23 |
Family
ID=39738201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08721158.7T DK2123271T3 (da) | 2007-03-07 | 2008-03-03 | Lægemiddel til behandling af influenza |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20100204314A1 (da) |
| EP (1) | EP2123271B1 (da) |
| JP (2) | JP5286251B2 (da) |
| KR (1) | KR101473028B1 (da) |
| CN (1) | CN101715343B (da) |
| AT (1) | ATE526960T1 (da) |
| CA (1) | CA2680415A1 (da) |
| CY (1) | CY1112201T1 (da) |
| DK (1) | DK2123271T3 (da) |
| ES (1) | ES2372996T3 (da) |
| HR (1) | HRP20110861T1 (da) |
| PL (1) | PL2123271T3 (da) |
| PT (1) | PT2123271E (da) |
| SI (1) | SI2123271T1 (da) |
| TW (1) | TWI424841B (da) |
| WO (1) | WO2008108323A1 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| DK2318832T3 (da) | 2008-07-15 | 2014-01-20 | Academia Sinica | Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| DK2568976T3 (da) * | 2010-05-10 | 2016-01-11 | Academia Sinica | Zanamivir-phosphonat-kongener med anti-influenzaaktivitet og fastlæggelse af oseltamivir-følsomhed hos influenzavira |
| CN103974945B (zh) * | 2011-12-16 | 2016-03-09 | 第一三共株式会社 | 用于制备神经氨酸衍生物的方法 |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| US9914956B2 (en) | 2012-08-18 | 2018-03-13 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| WO2014210397A1 (en) | 2013-06-26 | 2014-12-31 | Academia Sinica | Rm2 antigens and use thereof |
| EP3013347B1 (en) | 2013-06-27 | 2019-12-11 | Academia Sinica | Glycan conjugates and use thereof |
| EP3041484B1 (en) | 2013-09-06 | 2021-03-03 | Academia Sinica | Human inkt cell activation using glycolipids with altered glycosyl groups |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| KR20160104727A (ko) | 2014-01-16 | 2016-09-05 | 아카데미아 시니카 | 암의 치료 및 검출을 위한 조성물 및 방법 |
| TWI797430B (zh) | 2014-03-27 | 2023-04-01 | 中央研究院 | 反應性標記化合物及其用途 |
| KR20170010003A (ko) | 2014-05-27 | 2017-01-25 | 아카데미아 시니카 | 박테로이드 기원의 푸코시다제 및 이의 사용 방법 |
| EP4116329A1 (en) | 2014-05-27 | 2023-01-11 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| JP2017518989A (ja) | 2014-05-27 | 2017-07-13 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | 抗ｃｄ２０糖操作抗体群およびその使用 |
| JP7063538B2 (ja) | 2014-05-28 | 2022-05-09 | アカデミア シニカ | 抗ＴＮＦα糖操作抗体群およびその使用 |
| EP3191500A4 (en) | 2014-09-08 | 2018-04-11 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| CN109195996A (zh) | 2016-03-08 | 2019-01-11 | 中央研究院 | N-聚醣及其阵列的模组化合成方法 |
| CA3034057A1 (en) | 2016-08-22 | 2018-03-01 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
| US12685741B2 (en) * | 2017-10-11 | 2026-07-21 | Lifescience As | N-acetylneuraminic acid compositions and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6340702B1 (en) * | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP3209946B2 (ja) * | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| DK0823428T3 (da) * | 1996-07-22 | 2002-02-18 | Sankyo Co | Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse |
| JP4151800B2 (ja) | 1996-08-13 | 2008-09-17 | 第一三共株式会社 | ノイラミン酸化合物 |
| JP3920041B2 (ja) * | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| ATE414215T1 (de) | 2005-08-22 | 2008-11-15 | Delphi Tech Inc | Nockenwellenversteller zur einstellung der phase zwischen einer nockenwelle und einem antriebsrad |
-
2008
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-03 EP EP08721158A patent/EP2123271B1/en not_active Not-in-force
- 2008-03-03 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja not_active Ceased
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active Active
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
-
2011
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
-
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140018418A1 (en) | 2014-01-16 |
| EP2123271B1 (en) | 2011-10-05 |
| EP2123271A4 (en) | 2010-03-17 |
| HRP20110861T1 (hr) | 2011-12-31 |
| KR20090129414A (ko) | 2009-12-16 |
| JP2013139483A (ja) | 2013-07-18 |
| SI2123271T1 (sl) | 2012-05-31 |
| CN101715343B (zh) | 2012-09-26 |
| ES2372996T3 (es) | 2012-01-30 |
| WO2008108323A1 (ja) | 2008-09-12 |
| JP5286251B2 (ja) | 2013-09-11 |
| HK1137142A1 (en) | 2010-07-23 |
| ATE526960T1 (de) | 2011-10-15 |
| CA2680415A1 (en) | 2008-09-12 |
| PL2123271T3 (pl) | 2012-03-30 |
| JPWO2008108323A1 (ja) | 2010-06-17 |
| US20100204314A1 (en) | 2010-08-12 |
| TWI424841B (zh) | 2014-02-01 |
| TW200848018A (en) | 2008-12-16 |
| KR101473028B1 (ko) | 2014-12-15 |
| JP6012076B2 (ja) | 2016-10-25 |
| CY1112201T1 (el) | 2015-12-09 |
| PT2123271E (pt) | 2011-12-20 |
| CN101715343A (zh) | 2010-05-26 |
| EP2123271A1 (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2123271T3 (pl) | Lek do leczenia grypy | |
| PT2192109E (pt) | Derivado de -aminoácido bicíclico | |
| BRPI1009637A2 (pt) | composto, composição e uso de um composto | |
| BR112012014858A2 (pt) | agente antiplaqueta | |
| HRP20120323T1 (en) | Diarylhydantoin compounds | |
| UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
| DK2080516T3 (da) | Anvendelse af isothiocyanatderivater som anti-myelom-midler | |
| WO2005074603A3 (en) | Aminobenzoxazoles as therapeutic agents | |
| CR10499A (es) | Profarmaco de compuesto de cinamida | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| DK1987025T3 (da) | Benzoxazinon og benzoxazepinonoxazolidinoner som antibakterielle midler | |
| DK1696905T3 (da) | Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson | |
| HK1202288A1 (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives | |
| MA32192B1 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
| MX2009012125A (es) | Compuestos terapeuticos. | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| MY160882A (en) | Biocidal composition and method | |
| BR112012027387A2 (pt) | composição para controle de doenças de plantas e uso da mesma | |
| WO2009051223A1 (ja) | 白内障処置のための医薬組成物 | |
| EP2602254A4 (en) | HETEROCYCLIC CONNECTION | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| ATE441630T1 (de) | Substituierte cyclopenten-verbindungen | |
| BRPI0512970A (pt) | prodrogas de inibidores da hiv protease | |
| NO20064344L (no) | Caspaseinhibitorer og anvendelser derav |